Importance of proapoptotic protein PUMA in cell radioresistance
Jazyk angličtina Země Česko Médium print
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
PubMed
24785107
DOI
10.14712/fb2014060020053
PII: file/5715/FB2014A0007.pdf
Knihovny.cz E-zdroje
- MeSH
- apoptóza účinky léků MeSH
- benzothiazoly farmakologie MeSH
- kontrolní body buněčného cyklu účinky léků MeSH
- myši MeSH
- nádorové supresorové proteiny genetika metabolismus MeSH
- proteiny regulující apoptózu genetika metabolismus MeSH
- protoonkogenní proteiny genetika metabolismus MeSH
- toluen analogy a deriváty farmakologie MeSH
- zvířata MeSH
- Check Tag
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
- Názvy látek
- BBC3 protein, human MeSH Prohlížeč
- benzothiazoly MeSH
- nádorové supresorové proteiny MeSH
- pifithrin MeSH Prohlížeč
- proteiny regulující apoptózu MeSH
- protoonkogenní proteiny MeSH
- PUMA protein, mouse MeSH Prohlížeč
- toluen MeSH
Protein p53 plays an essential role in the induction of apoptosis by ionizing radiation in haemopoietic cells, the damage of which is the main reason for the development of bone marrow post-irradiation syndrome. p53 activation leads to an increase in the Bcl-2 family pro-apoptotic protein PUMA level. PUMA inhibits all the five anti-apoptotic proteins (Mcl-1, Bcl-2, Bcl-XL, Bcl-W and A1) and directly triggers apoptosis mediated by pro-apoptotic proteins Bax/Bak. In proliferating cells, knockout of p53 inhibits apoptosis on the one hand, but on the other disables the cellular division arrest moderated by p21Cip1/Waf1. The radioprotective effect of p53 inhibitor pifithrin was obvious at radiation doses causing the bone marrow syndrome. Knockout of PUMA also exerts its radioprotective effect through blocking the apoptosis induction, but the arrest of cells in the cell cycle through p21 induction is not abolished. PUMA -/- mice are radioresistant in terms of the development of post-irradiation syndrome after all radiation doses. Small molecules are being searched for that could prevent binding of PUMA with Bcl-2 family anti-apoptotic proteins. This would result in apoptosis inhibition and radioprotective or mitigating effects of these inhibitors.
Citace poskytuje Crossref.org